Literature DB >> 6788326

Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis.

P M Dowd, I B Kovacs, C J Bland, J D Kirby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6788326      PMCID： PMC1506187          DOI： 10.1136/bmj.283.6287.350

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  A possible role for cyclic nucleotides in the regulation of erythrocyte shape and permeability.

Authors:  Y Yawata; H S Jacob; N Matsumoto; J White
Journal:  J Lab Clin Med       Date:  1976-10

2.  A simple method for measuring red cell deformability in models of the microcirculation.

Authors:  H Schmid-Schönbein; J Weiss; H Ludwig
Journal:  Blut       Date:  1973-06
  2 in total
  11 in total

1.  Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma.

Authors:  J Keller; A Kaltenecker; K T Schricker; B Neidhardt; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

2.  Effects of indomethacin and sulindac on blood pressure of hypertensive patients.

Authors:  L O Simpson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

3.  In vitro and ex vivo effects of indobufen on red blood cell deformability.

Authors:  S Grasselli; R Guerciolini; V Iadevaia; P Parise; P Gresele; G G Nenci
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Plasma or serum from patients with systemic sclerosis alters behaviour of normal erythrocytes.

Authors:  I B Kovacs; M H Rustin; R H Thomas; C Ridler; S O Sowemimo-Coker; J D Kirby
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

5.  Prostacyclin increases filterability of normal and rigidified human red blood cells in vitro.

Authors:  I B Kovacs; J O'Grady
Journal:  Agents Actions       Date:  1984-02

6.  No decreased erythrocyte deformability in type 1 (insulin-dependent) diabetes, either by filtration or by ektacytometry.

Authors:  N H Schut; E C van Arkel; M R Hardeman; H J Bilo; R P Michels; J Vreeken
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

7.  A selective thromboxane synthetase inhibitor, OKY-046, fails to improve blood rheology in endotoxin-shocked rabbits.

Authors:  T Kato; K Hayashi; K Takamizawa; N Tsushima
Journal:  J Anesth       Date:  1991-07       Impact factor: 2.078

8.  Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.

Authors:  G S Lucas; M H Simms; N M Caldwell; S J Alexander; J Stuart
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

9.  Assessment of platelet function in patients with Raynaud's syndrome.

Authors:  R A Hutton; D P Mikhailidis; R M Bernstein; J Y Jeremy; G R Hughes; P Dandona
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

10.  Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study.

Authors:  J J Belch; H A Capell; E D Cooke; J D Kirby; C S Lau; R Madhok; E Murphy; M Steinberg
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.